Nutraferon RABEETO Capsules

Rabeprazole has a higher pKa (~5.0), allowing it to convert to its active pump-blocking form faster on Day 1, and it is cleared primarily via a non-enzymatic pathway rather than relying heavily on polymorphic CYP2C19 liver enzymes.

Taking the capsule 30 to 60 minutes before eating ensures Rabeprazole reaches parietal cells just as breakfast activates proton pumps, while allowing Domperidone to stimulate gastric contractions ahead of food intake.

Zollinger-Ellison syndrome requires 60 mg to 120 mg of Rabeprazole daily. Because each Nutraferon RABEETO capsule also contains 30 mg of Domperidone (the maximum safe daily dose of Domperidone), patients requiring high-dose PPI titration must use standalone PPI tablets rather than taking multiple RABEETO capsules.

No. It is a scheduled prescription therapy designed for continuous daily courses (typically 4 to 8 weeks) under physician supervision.

Domperidone prolongs the cardiac QTc interval and is strictly contraindicated in congenital long QT syndrome, moderate-to-severe hepatic impairment, prolactinoma, GI haemorrhage/obstruction/perforation, or concurrent use of potent CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, erythromycin, ritonavir, diltiazem, verapamil). Rabeprazole is also contraindicated with Rilpivirine and reduces absorption of Atazanavir and Ketoconazole.